Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere for about $4.48 billion, ending a prolonged legal battle over its plan to buy the diagnostic-testing company. Abbott’s ...

Alere Inc alleges Abbott Laboratories is trying to stymie its planned $5.8 billion takeover of the diagnostics company by purposefully delaying key submissions to anti-trust regulators, according to a ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...

Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. Talk about coming down with a case of buyer’s remorse. Just 10 months after Abbott Laboratories announced ...

The Delaware Court of Chancery appears positioned to once again decide whether to keep afloat a once-promising multibillion-dollar merger that has since struck the rocks in a pair of dueling breach of ...

Alere agreed to pay $33.2 million to resolve False Claims Act allegations that it knowingly sold defective point-of-care diagnostic testing devices. Here are five insights. 1. The U.S. Justice ...

Alere has become a popular name for a digital health sector that’s hoping to see some early-stage acquisitions. But every read-between-the-lines comment from Dr. Craig Keyes, the company’s president ...

Shares of Alere plunged Friday morning after the company disclosed in a filing that one of its units has seen its Medicare enrollment revoked. The Centers for Medicare & Medicaid Services alleged that ...